Perspectives on Genetic and Genomic Technologies in an Academic Medical Center: The Duke Experience
In this age of personalized medicine, genetic and genomic testing is expected to become instrumental in health care delivery, but little is known about its actual implementation in clinical practice. Methods. We surveyed Duke faculty and healthcare providers to examine the extent of genetic and geno...
Main Authors: | Sara Huston Katsanis, Mollie A. Minear, Allison Vorderstrasse, Nancy Yang, Jason W. Reeves, Tejinder Rakhra-Burris, Robert Cook-Deegan, Geoffrey S. Ginsburg, Leigh Ann Simmons |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2015-04-01
|
Series: | Journal of Personalized Medicine |
Subjects: | |
Online Access: | http://www.mdpi.com/2075-4426/5/2/67 |
Similar Items
-
Parental Reasons and Reactions toward Return of CYP2D6 Research Results and Perceived Benefits and Harms toward Hypothetical Incidental Findings
by: Adelsperger, Sarah
Published: (2015) -
Pharmacogenetic Testing: A Tool for Personalized Drug Therapy Optimization
by: Kristina A. Malsagova, et al.
Published: (2020-12-01) -
What Are the Barriers and Enablers to the Implementation of Pharmacogenetic Testing in Mental Health Care Settings?
by: Adam Jameson, et al.
Published: (2021-09-01) -
Physician-Reported Benefits and Barriers to Clinical Implementation of Genomic Medicine: A Multi-Site IGNITE-Network Survey
by: Aniwaa Owusu Obeng, et al.
Published: (2018-07-01) -
What Results Should Be Returned from Opportunistic Screening in Translational Research?
by: Colin ME Halverson, et al.
Published: (2020-03-01)